pharmaceutical investing Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
pharmaceutical investing Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue
pharmaceutical investing Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003
pharmaceutical investing EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
pharmaceutical investing Pernix Therapeutics Announces Return to Market of Zohydro ER with BeadTek 20 mg
pharmaceutical investing Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
